272
Participants
Start Date
April 9, 2024
Primary Completion Date
November 27, 2030
Study Completion Date
April 14, 2031
TAR-200
Participants will receive TAR-200 intravesically.
Mitomycin C
Participants will receive MMC intravesically.
Gemcitabine
Participants will receive gemcitabine intravesically.
Cliniques Universitaires Saint Luc, Brussels
Ziekenhuis Oost-Limburg, Genk
Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica, Córdoba
AZ Sint-Jan, Bruges
Algemeen Ziekenhuis Delta, Roeselare
Algemeen ziekenhuis Maria Middelares, Ghent
PO Molinette Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, Torino
National Cancer Center, Gyeonggi-do
Institut Paoli Calmettes, Marseille
Associated Medical Professionals, Syracuse
Centers for Advanced Urology LLC d b a MidLantic Urology, Bala-Cynwyd
Istituto Clinico Humanitas, Rozzano
San Raffaele Hospital, Milan
Istituto Dei Tumori Di Milano, Milan
Universitatsklinikum Schleswig Holstein Campus Lubeck, Lübeck
Hosp. Gral. Univ. Gregorio Maranon, Madrid
Hosp. Univ. 12 de Octubre, Madrid
Chungbuk National University Hospital, Chungcheongbuk Do
Hosp Virgen de La Victoria, Málaga
Ralph H. Johnson Veterans Affairs Medical Center, Charleston
Low Country Urology Clinics, North Charleston
Carolina Urologic Research Center, Myrtle Beach
Clinique de la Croix du Sud, Quint-Fonsegrives
Florida Urology Partners, Riverview
Chu Rennes Hopital Pontchaillou, Rennes
Urology Associates, Nashville
Vanderbilt University Medical Center, Nashville
Hosp. Univ. Marques de Valdecilla, Santander
Urologie Neandertal Praxis Mettmann, Mettmann
Hosp. Virgen Del Rocio, Seville
Keimyung University Dongsan Hospital, Daegu
Central Ohio Urology Group, Gahanna
The Urology Group, Cincinnati
Hosp. Clinico Univ. de Valencia, Valencia
Urology of Indiana, Carmel
First Urology, PSC, Jeffersonville
Comprehensive Urology, Royal Oak
Ospedale S. Maria Delle Croci, Ravenna
Pusan National University Yangsan Hospital, Yangsan
Universitaetsklinikum Koeln, Cologne
Klinikum Leverkusen gGmbH, Leverkusen
Ospedale San Donato, Arezzo
Chonnam National University Hwasun Hospital, Jeollanam-do
Hopital Claude Huriez, Lille
UroPartners, Chicago Ridge
Northwestern University, Chicago
Ospedale Provinciale di Macerata, Macerata
Specialty Clinical Research of St Louis, St Louis
Wichita Urology Group, Wichita
Arkansas Urology, Little Rock
APHP - Hopital Bichat - Claude Bernard, Paris
Urology Clinics of North Texas, Dallas
University of Texas Southwestern Medical Center, Dallas
Houston Metro Urology, Houston
Urology Austin, Austin
Colorado Clinical Research, Lakewood
Klinikum der Universitaet Muenchen, München
Polyclinique de Limoges - Francois Chenieux, Limoges
USC Norris Comprehensive Cancer Center, Los Angeles
Genesis Research LLC, Torrance
Genesis Research LLC, Los Alamitos
Hopital Foch, Suresnes
University of California Irvine Medical Center, Orange
Spokane Urology, Spokane
Peking University First Hospital, Beijing
Shengjing Hospital Of China Medical University, Shenyang
Tianjin Medical University Cancer Institute and Hospital, Tianjin
The Second Hospital Of Tianjin Medical University, Tianjin
Spitalul Clinic Judetean de Urgenta Pius Brinzeu, Timișoara
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Institutul Oncologic Ion Chiricuta, Cluj-Napoca
Chongqing Cancer Hospital, Chongqing
Regina Maria, Cluj-Napoca
Tongji Medical College of Huazhong University Science Technology of Medicine Health Management, Wuhan
Centrul Medical Unirea SRL, Brasov
Sun Yat Sen University Cancer Center, Guangzhou
West China School of Medicine/West China Hospital, Sichuan University, Cheng Du Shi
Xi an Jiaotong University Hospital, Xi'an
University of California San Francisco, San Francisco
Clinica Santa Isabel, Buenos Aires
Investigaciones Clinico Moleculares (ICM), CABA
Centro Urologico Profesor Bengio, Córdoba
Hospital Privado de la Comunidad, Mar del Plata
Fundacao Pio XII, Barretos
NAIC Nair Antunes Instituto do Cancer, Bauru
Hospital das Clinicas da Universidade Estadual de Campinas UNICAMP, Campinas
Liga Paranaense de Combate ao Cancer, Curitiba
Irmandade Santa Casa de Misericordia de Porto Alegre, Porto Alegre
Hospital da Bahia, Salvador
Sociedade Beneficente de Senhoras Hospital Sirio Libanes, São Paulo
Real e Benemérita Associação Portuguesa de Beneficência, São Paulo
Fundacao Antonio Prudente A C Camargo Cancer Center, São Paulo
Universitaetsklinikum Halle Saale, Halle
Universita Campus Bio-Medico di Roma, Roma
Istituto Nazionale Tumori Regina Elena, Roma
Funabashi Municipal Medical Center, Funabashi Shi
Hakodate Goryoukaku Hospital, Hakodate
Hyogo Prefectural Amagasaki General Medical Center, Hyōgo
Niigata Cancer Center Hospital, Niigata
National Hospital Organization Okayama Medical Center, Okayama
Toho University Sakura Medical Center, Sakura
Toranomon Hospital, Tokyo
Yokohama City University Medical Center, Yokohama
Uniwersytecki Szpital Kliniczny w Bialymstoku, Bialystok
IN VIVO Sp. z o.o, Bydgoszcz
Szpital Uniwersytecki w Krakowie, Krakow
Uniwersytecki Szpital Kliniczny nr 4, Lublin
Wojewodzki Szpital im Sw Ojca Pio w Przemyslu, Przemyśl
Szpital Wojewodzki im Sw Lukasza SP ZOZ, Tarnów
MICS Centrum Medyczne Torun, Torun
Mazowiecki Szpital Onkologiczny, Wieliszew
Dolnoslaskie Centrum Onkologii, Wroclaw
Ponderas Academic Hospital, Bucharest
Seoul National University Hospital, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea Seoul St Mary s Hospital, Seoul
Hosp. Univ. Germans Trias I Pujol, Badalona
Fund. Puigvert, Barcelona
Hosp.Univ.Parc Tauli, Sabadell
St Bartholomews Hospital, London
Salford Royal Hospital, Salford
Southampton University Hospital, Southampton
Lister Hospital, Stevenage
Janssen Research & Development, LLC
INDUSTRY